MedTrace Logo

Multi-center Study of Residual Neuromuscular Block Incidence in the Post-anesthesia Care Unit

NCT02226809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 763

Last updated 2014-08-27

No results posted yet for this study

Summary

Residual neuromuscular block (RNMB) is frequent in the immediate postoperative period and is a source of complications, mainly respiratory. The incidence is variable due to multiple factors. In Spain the incidence is unknown.

The investigators hypothesize that a number of patients in the postanesthesia care unit (PACU) present with RNMB after general anesthesia using intermediate action neuromuscular block agents (NMBA).

The main objective is to know the incidence of RNMB in Spanish hospitals. Secondary objectives are to observe the possible relationship with other pre- and intraoperative factors.

Conditions

  • Incomplete Reversal of Neuromuscular Block
  • Postoperative Respiratory Complications

Interventions

DEVICE

Accelerometry

Application of TOF stimulus (40 mA, three to four times) and recording TOFr in the PACU

Sponsors & Collaborators

  • General University Hospital of Valencia

    collaborator OTHER

  • Hospital General Universitario Gregorio Marañon

    collaborator OTHER

  • University of Valencia

    lead OTHER

Principal Investigators

  • Carlos L Errando, MD, PhD · Servicio de Anestesiologia. Consorcio Hospital General Universitario de Valencia

  • Ignacio Garutti, MD, PhD · Servicio de Anestesiologia. Hospital Universitario Gregorio Marañon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02226809 on ClinicalTrials.gov